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Abstract  
Several studies results have shown that mode of delivery affects the health of children, and recent 
studies showed that elective Caesarean section (CS) is associated with aberrant short-term immune 
responses in the newborn infant and an increased risk of developing immune disorders. This article 
focused on the effect and role of the C-section on the immune development in children. Begin at 
pregnancy, the infant's immune system is activated and develops years after birth. In this article we 
find that cesarean delivery mode will influence the offspring's immune system by disrupting the 
intestinal tract's bacterial colonization, different levels of birth adaptive stress, and altering gene 
expression epigenetic regulation. Some studies have found that gut microbiome composition plays 
a significant role in the development of immune system along with other factors such as 
diet/lifestyle, antibiotic use, formula feeding, vaccination with life vaccine, and pathogen exposure. 
In early life, disrupted colonization induced dysbiosis that was associated with lower Bifidobacteria 
and higher counts of C. difficile. These findings are related to infant immune disease and allergy. 
Dysbiosis following C-section has a huge effect of developing altered immune system, and this 
microbiome imbalance can be controlled by nutritional support such as maternal breast milk or the 
use of different combinations of prebiotics and probiotics (synbiotic) which could be beneficial for 
the immune and metabolic system.  




Caesarean section (C-section) is a surgical 
procedure developed to prevent or treat life-
threatening maternal or fetal complications such as 
antepartum hemorrhage, fetal distress, abnormal 
fetal presentation, and hypertensive disease.1 The 
number of C-section in the US has risen by up to 
48% since 1996.2 The WHO recommends that in up  
 
 
to 15% of deliveries, C-section may be indicated. 
However, 37 of 60 developed countries currently 
surpassing this guideline and taking women 
undergoing pre-labor, elective C-section without a 
clear medical indication may present risks to the 
child.2,3 Simultaneously with the increase of rising 
C-section levels, there has been an increasing 
number of autoimmune and allergic diseases.4 
Possible mechanisms for these associations may 
include lower and untimely activation of the fetal 
immune system due to lack of stress response caused 
by contraction of the uterus and fetal hypoxia,3 and 
alteration of the bacterial colonization of the infant’s 
gut after C-section.2 
Dysbiosis occurs when there is irregular 
colonization of the body intestine, also considered to 
be a mismatch between commensal and pathogenic 
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microbes.5 Intestinal bacterial flora is critical for 
immune growth, and children with atopic diseases 
have been shown to have lower gut levels of 
Bacteroides and Bifidobacterium species than 
children without atopic disease. Bifidobacteria are 
associated with reduced risk of atopic disease in 
children. C-section has been shown to disrupt and 
change the development of bacterial intestinal flora 
in infants. This may, in turn, alter development of 
the immune system and increase the risk of atopic 
disease in children.6 
Uterus contraction and fetal hypoxia during 
childbirth cause a stress response in both the mother 
and the fetus, raising the substantial levels of cortisol 
and catecholamine in newborns. Multiple studies 
show a low level of cortisol and catecholamine in the 
absence of contraction in the C-section delivery, 
variations in levels of stress hormones at birth may 
alter the immune responses and influence the 
immune system later in life.3,7 Cortisol may remove 
uterine preleukemic clones.7 There is also evidence 
of altered DNA methylation patterns that are 




This article focused on how the delivery mode 
affects the neonate's immune system. This analysis 
was prepared by conducting a search to identify 
related journals and articles published in 2010 until 
before April 2020 in several electronic databases, 
i.e. Pubmed and Medline. The search terms included 
variants of "delivery mode," "cesarean section," 
"immune system," "allergy," "asthma," "diabetes," 
"celiac disease," "allergy to food," "prebiotic" and 
"probiotic" Additional articles were found by 
manual search, either in English or Indonesian, from 
manual references cited in relevant reviews. 
 
Results and Discussion 
 
Immune development in early life 
 
Immune activation starts from insemination as the 
first immune system exposure to paternal 
alloantigens. Likewise, it contains paternal immune 
cells and substances, such as estrogen and 
testosterone, prostaglandins and various signaling 
molecules, including IL-8, TGF-b, and IFN-C. It 
also promotes the transfer and expansion of 
regulatory T cells (Treg) and promotes the activation 
and proliferation of dendritic cells (DCs) in 
responsive cells. Treg is probably involved in T-
cells suppression of the mother's effector that 
promote the success of pregnancy. B cells secrete 
antibodies that once shield paternal antigens found 
in the trophoblast on the fetal-maternal interface. 
The phenotypes of immune cell function, i.e. DC, 
turning or remaining unchanged and thus tolerant, 
are modulated by a wide range of molecules formed 
or secreted by the trophoblast itself, such as the 
human chorionic gonadotropin (hCG), Heme 
Oxygenase-1 (HO-1), Regulated on activation, 
normal T cell expressed and secreted (RANTES), 
and pregnancy-specific glycoprotein (PSG).9 
Additionally, cell-secreted molecules such as Gal-1 
secreted by uterine Natural Killer cells (uNKs) and 
uterine Mast Cells (uMCs) can have a positive effect 
on trophoblast physiology while making maternal T 
cells become receptive or remain to the fetus. These 
findings suggest that seminal plasma plays an 
important role in the uterine system preparation for 
the embryo implantation.9,10  
A labor will stimulate immune response within 
the uterine cavity which will be absent in the case of 
elective C-sections. The production of 
proinflammatory cytokines in the uterine 
environment such as interleukin (IL)-1β, IL-6, IL-8 
and tumour necrosis factor-α (TNF-α) is thought to 
be responsible for an activation of the fetal immune 
system during labor. This reflects the increased of 
leukocytes in neonates’ circulation.11 
As in all mammals, fetal immune production has 
been observed at 3-4 weeks of gestation, where the 
pluripotent erythroid and granulomacrophage 
progenitors can be found in human embryo’s yolk 
sac. These primitive cells migrate to the liver, which 
becomes the main haemopoiesis site at 5±6 weeks of 
gestation, thereby increasing the size of the liver and 
increasing the number of nucleated cells. A discrete 
granulocyte/macrophage population is growing at 
this time.12 Nevertheless, the neutrophil will not be 
noticed until the end of the third trimester. As a 
result, newborn and, in particular, premature infants 
have impaired neutrophil activity, putting the child 
at risk of bacterial infections.13 
In the uterus, the fetus has an immune system 
that is tolerant to maternal alloantigens. The 
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mother’s uterine natural killer (uNKs) cells, 
immature dendritic cells (iDCs), T cells and 
macrophages help to modulate the uterine 
environment in order to support successful 
pregnancy.14 This system will continue after birth 
when the enormous exposure to environmental 
antigens, many of which are derived from intestinal 
commensal bacteria, calls for a rapid change in order 
establish distinct immune responses that are 
appropriate for the infant in early life.13 
The immune system is not fully functioning at 
birth and therefore infants are at an elevated risk of 
infection. After birth, infants are moving from the 
sterile environment of the womb to the wider world, 
exposed to a wide range of diseases they have never 
experienced and have no protection against. The 
‘hygiene hypothesis’ theory postulates that early life 
preparation of the immune system arising from 
essential immune modulatory exposures helps to 
stimulate regulatory mechanisms that protect against 
infectious diseases and allergy.15  
The definition of allergy has also evolved over 
the years, and currently, it is considered an umbrella 
term for an immune defect resulting in the lack of 
tolerance to usually harmless antigens.16 Tolerance 
is antigen-specific and the loss of tolerance in 
allergies seems to be related to the timing, rate and 
context of environmental exposures in early life, 
including bacterial colonization of the infant gut. 17 
Specific early microbial intestinal exposure is 
thought to significantly reduce the incidence of 
inflammatory, autoimmune and atopic diseases 
further fuel the scientific view that microbial 
colonization plays an important role in regulating 
and fine-tuning the immune system throughout 
life.12,18 As a major part of the mucosal immune 
system, the gut-associated lymphoid tissue (GALT) 
has M cells that collect small particles and 
effectively transport them from the intestine to 




The innate and adaptive immune system 
 
Microorganisms that successfully enter the body 
will be immediately recognized by the cells and 
mechanisms of the innate immune system within 
hours of an antigen-specific response being 
developed by the adaptive immune system a few 
days later.18,19. Innate immune cells are commonly 
located along with physical barriers such as skin and 
mucous membranes, where they release defensive 
biomolecules such as defensins and complements. 
Upon pathogen identification, dendritic cells and 
macrophages (often known as antigen-presenting 
cells, APCs) are activated to phagocytose the 
invader, digest, and process pieces (antigens) on the 
cell surface in the form of major histocompatibility 
complex (MHC) molecules.20 Adaptive cells include 
T-cells that primarily target intracellular microbes, 
along with B-cells that produce antibodies, most of 
which target extracellular pathogens. Innate 
immunity is primarily involved in the initial control 
of microbes. Adaptive defense is mainly concerned 
with the final clearance of the invader. Adaptive 
immunity also maintains certain cells as immune 
memory cells; these antigen-experienced memory 
cells do not need the same degree of innate immune 
support for secondary infection with the same (or 
similar) pathogen and react much faster and more 
efficiently.19 
 
Impact of C-section on child’s immune 
development 
 
For the postnatal development of the immune 
system, it is important to microbially colonize the 
infant gut gastrointestinal tract. C-Section delivered 
infants, either lacked or displayed a slow 
colonization of one of the main intestinal phylums, 
the Bacteroidetes, because the infant does not enter 
the mother's birth canal. Therefore, the delayed 
colonization leads to low-diversity of the intestinal 
microbiota, which leads to a lack of regulatory T cell 
and/or Th1-like responses to avoid Th2 domination. 
In addition, the dysbiosis in the C-section children is 
associated with lower circulation of CXCL10 and 
CXCL11 chemokines related to Th-1 when the risk 
of allergies increases.6 
The "hygiene hypothesis" was introduced in 
1989 when researchers argued that the increase in 
allergic diseases was due to a lack in microbial 
exposure due to improved sanitization practices 
following a low incidence of early childhood allergy 
infection.21 Modern medicines and changes in 
sanitation and public health have led to an era of 
unprecedented cleanliness and the near eradication 
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of previously common pathogens. However, these 
improvements coincided with the rise of 
autoimmune diseases and other immune disorders. 
Strachan and others indicated that a certain amount 
of microbial stimulation is required to prevent 
disease.5 Microbiome includes both pathogens and 
commensals, which play a role in immune 
development. 
In addition to exposure to parasites outside the 
body, as many as 100 trillion microbes colonize 
barrier sites within our body, most of which are in 
the intestine, indicating how the gut serves as one of 
the major organ in which the immune system is 
developed. The composition of the microbiome is 
dynamic and strongly affected by external factors 
such as mode of birth, diet/lifestyle, antibiotic usage, 
vaccination, formula feeding and pathogen 
exposure. This process is necessary to educate the 
immune system on how to respond to a wide range 
of stimuli encountered. Given the intricate 
communication between the gut microbiota and 
immune system, which plays a role in the 
development of tolerance and immune 
programming, disruption of the diversity and/or the 
function of the microbiota referred to as dysbiosis 
may increase risk of immune disorders such as 
allergy.21 
There are significant shifts in the makeup of the 
intestinal microbiota during early life. The intestines 
are sterile at birth. Within a few hours, the bacteria 
will begin to appear in the feces. The bacteria 
colonizing the infant intestine during the first days 
of childhood derive mainly from the mother and the 
environment. The mode of transmission is therefore 
the key determinant of intestinal microbiota.22 
Vaginal infant microbiota (<24 h postpartum) 
resembles the vaginal microbiota of the mother and 
is common across various body habitats (skin, oral, 
nasopharynx, birth canal, and feces), whereas in 
neonates born by C-section is identical to the skin 
microbiota of the mother.6,22,25 The C-section was 
correlated with lower Bifidobacteria counts, lower 
colonization rates and counts of B. fragilis species, 
and higher counts of C. difficile.22 Infants with a 
higher number of Bifidobacteria species at 1 month 
of age have higher rates of salivary IgA, which also 
correlates with allergic symptoms defense.5 The 
additional prophylactic antibiotic given in C-section 
may also lead to aberrant microbial colonization in 
the infant intestine and may increase susceptibility 
to metabolic disease in later life.26 C. difficile was 
also the single gut microbe investigated that was 
associated with an increased risk for asthma, but this 
association was restricted to those children with 
atopic parents.25 
Another research stated that there is a lack of 
stress hormones in the infant born by the C-section. 
Contraction and oxygen hypoxia during vaginal 
delivery are known to promote the development of 
stress hormones such as catecholamine and 
cortisol.3,27 Cortisol elevation at birth is a predictor 
of hypothalamic-pituitary-adrenal axis activation of 
the immune system, lung and organ maturation, and 
neurogenesis. Vaginal delivery and its effects on 
elevating glucocorticoids have been associated with 
increased maturation of the organs, including the 
intestine. These two stress hormones, on the other 
hand, are less present in infants born by C-section 
before labor.3 Another experimental study showed 
that the use of synthetic oxytocin, antibiotics or 
infants delivered by the C-section had higher global 
DNA methylation in the cord blood cells, and this 
neonatal epigenetic modification has implications 
for the wellbeing of the offspring.28 Higher global 
DNA methylation could be involved in silencing the 
pathway that controls the balance between T-helper 
type 1 and 2 cells, which could lead to a higher risk 
of developing immune diseases.29 Further studies on 
this hypothesis are needed. 
 
Health risks associated with altered immune 
development on child born by C-section 
 
Recent studies have shown that C-section delivery 
has been associated with short-term aberrant 
immune responses in newborn infants and a higher 
risk of developing immune diseases such as asthma, 
allergies, neonatal respiratory disease, type 1 
diabetes, celiac disease and malignancy.3,26,30 As 
mentioned, C-section delivery may alter immune 
development by three means: (1) disrupting bacterial 
colonization of the intestines; (2) mounting poor and 
inadequate stress response; and (3) altering 
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Respiratory system 
 
The risk of respiratory morbidity after elective CS is 
mainly related to gestational age in terms of 
neonates, but it also shows that the lack of work in 
elective CS may explain reduced production of 
catecholamines (also in preterm infants).3,27 This 
lack of hormones altered the lung adaptation and the 
associated clinical symptoms such as benign 
intermittent tachypnea, chronic neonate pulmonary 
hypertension, pulmonary air leakage and 
hypoxemia.27 
 
Asthma, allergic rhinitis and food allergy  
 
There are reports that there is a risk of developing 
allergic disease, allergic rhinitis, asthma and asthma 
hospitalization and food allergy, whereas there was 
no association with inhalant atopy and 
eczema/atopic dermatitis.25,31 Almqvist et al32 
reported the outcome of a cohort study in 2012 in 
which there was an increased risk of asthma and 
asthma diagnosis during the follow-up year in 
children born with a C-section. Increased risk of 
asthma medication in the emergency-born, but not 
elective, category suggests that there is no causal 
effect due to vaginal microflora. A more likely 
explanation should be sought in the emergency C-
section. Changed immune function in infants 
delivered by C-section compared to vaginal delivery 
is documented by reduced production of cytokines 
involved in neonatal immunity, in this respect 
increased levels of IL-13 and IFN-supposed 
associated with atopy.27 The frequent presence of C. 
difficile in the feces at 1 month post-partum by C-
section delivery has an association with the 
development of wheeze, eczema, and sensitization 
to food allergens in the first 2 years of life.25  
A recent cohort study from Mitselou N et al33 
using a large population database, shown an 
increased risk of food allergy in children born 
through elective or emergency Caesarean delivery 
compared to those delivered vaginally. This positive 
association aligned with the theory that exposure to 
vaginal microflora might reduce the risk of offspring 
atopic manifestations. The altered composition of 
the intestinal flora involves these improvements to 
the immune response to a more atopic profile. The 
colonization of intestinal microbes appears to 
stimulate a non-allergic Th1 reaction of the immune 
system while IgE synthesis seems to be 
downregulating. C-Sectional children are seemed to 
have weak immune recognition, especially when 
born to an allergic mother to foods that are supposed 
to be tolerated.34  
 
Type-1 diabetes mellitus 
  
Recent studies have shown that children born in the 
C-section are at more than 20% higher risk of 
childhood-onset type 1 diabetes mellitus relative to 
those born per-vaginam.3 Other studies have shown 
that increased type 1 diabetes mellitus is associated 
with altered development of the immune 
system.27,35,36 In addition, it has been previously 
suggested that children with decreased early-life 
exposure to microorganisms may be at increased 




Bacterial flora of the newborns plays a role in the 
development of celiac disease. Studies showed a 
positive association between elective C-section and 
development of celiac disease, but not for an 
emergency C-section.35,37 However, the incidence of 
inflammatory bowel disease has not been affected 
by the mode of delivery.3 Maternal microbial and 
immune status, infant nutrition and antibiotic 
exposure affect the development of the intestinal 
microbiome and therefore the development of the 
immune system. Dysbiosis can lead to immune-
mediated diseases, including allergies and 




There are indications of an increased risk of cancer 
(leukemia,3,7 neuroblastoma, testicular cancer) in 
children born by elective C-section compared to 
vaginal delivery. Although these correlations have 
not been verified or refuted in other studies.3 
 
Impact of C-section on risk of developing allergy 
 
In this study, mode of delivery was correlated with 
early childhood asthma and allergy. Children born in 
the C-section were at an increased risk of developing 
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childhood asthma, food allergy perhaps associated 
with risk for allergic rhinitis and atopic dermatitis. 
Although the mechanisms are not fully understood, 
it could involve the confounder such as maternal 
smoking, socioeconomic status or family history of 
asthma.32 Microflora plays a number of critical roles 
in the intestinal colonization and production and 
homeostasis of the immune system. Some of the 
strongest data linking dysbiosis and allergies are 
epidemiological associations with conditions that 
cause dysbiosis— particularly C-section.38 
The predominant sources of microbes for the 
initial colonization of GIT after birth are maternal 
microbiota, especially during birth delivery, and 
infant diet (breast versus formula feeding).22 The 
mode of delivery is a key factor that shapes the 
developing infant microbiota and, in this regard, 
infants delivered by the C-section have been 
reported to have an enteric microbiota that differs 
from infants delivered by the vagina, both in time of 
colonization and in composition. The modified 
microbiota may have an immunomodulatory effect 
that increases the child's susceptibility to poor 
immune recognition of foods that should be 
tolerated by food-specific IgE found in infants 
delivered by C-section.34  
 
Nutrition intervention to reduce risk of developing 
allergy 
 
Nutritional measures are key to early-life immune 
functioning by impacting the gut barrier through 
strengthening the intestinal microbiota and immune 
tolerance.39 Breast milk promotes the colonization 
and maturation of the infant gut microbiome, as it 
contains beneficial bacteria such as Staphylococcus, 
Streptococcus, Serratia, Pseudomonas, 
Corynebacterium, Ralstonia, Propionibacterium, 
Sphingomonas and Bradyrhizobiaceae. Breast milk 
definitely contributes to stimulate the growth of the 
microbiota strain specific to the gut Bifidobacterium 
found in the intestines of nursing infants along with 
Bacteroides and it can have an important effect on 
the development of immune tolerance and genomic 
capacity for metabolizing the human milk 
oligosaccharides (HMOs).24,40 As a prebiotic, 
HMOs have effects and benefits in the alteration of 
the intestinal microbiota, pathogens' counter-
adhesive effects, epithelial cell response modulation 
and immune system growth. HMOs are therefore 
beneficial in the treatment of dysbiosis in 
breastfeeding children. Moreover, some studies 
have shown that the role of nutrition intervention 
could also play in gut microbiota production for un-
breastfed babies.41,42  
Some clinical and preclinical studies 
demonstrate that synbiotics can prevent certain 
allergic diseases. This contributed to the use of 
synbiotic to compensate for early microbial bowel 
disruptions.43 World Allergy Organization (WAO) 
recommended using probiotics to avoid food allergy 
in pregnant women at high risk of having an allergic 
infant, women who breastfeed infants with high risk 
of developing allergy and infants with high risk of 
developing allergy.44 Prebiotic supplementation also 
recommended by WAO panel to prevent allergy in 
not-exclusively breastfed infants regardless of their 
allergic risk. However for the prebiotic 
recommendation is conditional and need a further 
strong certainty of evidences.45  
In the JULIUS study conducted by Chua et al,46 
the effect synbiotics on the gut microbiota has been 
determined in infants born by C-section.The result 
has shown that supplementation with specific 
synbiotic mixture (a mixture of short-chain galacto-
oligosaccharides (scGOS) and long-chain fructo-
oligosaccharides (lcFOS) and B.Breve M16-V in C-
section-born infants allows rapid colonization of 
Bifidobacteria from the first days of life and offers 
promising nutritional intervention in dysbiosis. 
Furthermore, safety follow-up showed a 
significantly lower incidence of reported skin-
related disorders and atopic dermatitis among those 
treated with this synbiotic compared to the control 
group.  
A randomized study of 90 exclusively atopic 
dermatitis (AD) at large-formula (eHF) plus 
synbiotic (a mixture of scGOS and LcFOS and 
Bifidobacterium breve M-16 V) showed significant 
modulation of the intestinal microbiota, with high 
percentages of bifidobacteria and lower percentages 
of Clostridium litusebrense/Clostridium 
histolyticum and Eubacterium rectale/Eubacterium. 
The synbiotic impact was sustained for one year 
following and the incidence of symptoms such as 
asthma and the use of asthma medications was 
significantly reduced.47 Potential role of synthesized 
human milk oligosaccharides (HMOs) has been 
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studied recently and are considered safe for infant 
nutrition to support microflora development.48 
In addition to this, future approach that provide 
combination of synbiotic and hydrolyzed formula 
might be modulate immune system in infants to 
support tolerance development. Hydrolyzed formula 
still contains certain protein fractions of different 
sizes. Some of them may have a role in inducing oral 
tolerance as recently shown in a study in 
combination of prebiotic mixture of scGOS and 
lcFOS lowering sensitization against cow’s milk-
specific IgG1 and higher level of dendritic and Treg 
cell, demonstrating its immune tolerance-inducing 
capacity.49 This indicates that the use of synbiotic in 
early life may be beneficial to compensate for gut 
microbiota dysbiosis, but more study is needed on 
the benefits of patient outcomes, particularly in 




Birth process can be a critical time point that decides 
the immune function of the offspring in later life. 
The mode of delivery has been associated with 
several infant conditions. Studies have shown that 
C-section has been associated with immune and 
allergic diseases caused by altered immune 
development compared to vaginal delivery. The 
potential mechanism for the C-section affecting the 
development of the immune system may be the 
alteration of bacterial colonization that causes 
dysbiosis or may be associated with adverse birth 
stress reactions and epigenetic modification of gene 
expression in the immune system. Moreover, 
dysbiosis causes immune imbalances and is thought 
to cause allergy, and synbiotic use may improve the 
immune condition of children. 
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